Skip Navigation

Cardiovascular Research 1997 35(3):431-441; doi:10.1016/S0008-6363(97)00159-4
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leor, J.
Right arrow Articles by Kloner, R. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leor, J.
Right arrow Articles by Kloner, R. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Gene transfer and cell transplant: an experimental approach to repair a ‘broken heart’

Jonathan Leora, Howard Prenticeb,c,d, Vittorio Sartorellib,c,d, Manuel J Quinonesb,c,d, Michael Pattersond, Laurence K Kedesb,c,d and Robert A Klonerc,d,*

aCardiology Division, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
bThe Institute of Genetic Medicine, Department of Medicine, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA
cDepartment of Biochemistry and Molecular Biology, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA
dThe Heart Institute, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA

* Corresponding author. The Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd., Los Angeles, CA 90017, USA. Tel.: +1 (213) 977 4050; fax: +1 (213) 977 4107.

Received 5 March 1997; accepted 27 May 1997

KEYWORDS Cardiomyocyte; Gene therapy; Myocardial infarction; Rat

The first 150 words of the full text of this article appear below.


    1 Introduction
 
Despite significant progress in prevention and therapy of ischemic heart disease, treating patients with heart failure after myocardial infarction remains a major therapeutic challenge. Adult cardiomyocytes cannot regenerate after injury. Therefore, cardiomyocyte loss due to myocardial infarction is irreversible. Currently, congestive heart failure is the only major cardiovascular disorder that is increasing in incidence and mortality [1]. Thus, there is still a need to develop alternative therapeutic strategies to prevent, arrest or reverse congestive heart failure after myocardial infarction.

Recent insights into the pathogenesis of myocardial disease and advances in molecular biology have opened up a new era of molecular and cellular therapies that target genes, molecules and peptides. Gene transfer as a therapeutic approach for the treatment of myocardial infarction and congestive heart failure has been suggested as a new treatment strategy for these serious disorders [2, 3]. The introduction, into injured myocardium, of recombinant transgenes that . . . [Full Text of this Article]


    2 Post-infarction left ventricular dysfunction
 

    3 Gene transfer into the ischemic or infarcted myocardium
 

    4 Molecular cardiomyoplasty: gene therapy with MyoD
 

    5 Cell transplant
 

    6 Other strategies
 

    7 Unresolved issues and challenges
 

    8 Summary and future research
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Khan, V. K. Kutala, D. S. Vikram, S. Wisel, S. M. Chacko, M. L. Kuppusamy, I. K. Mohan, J. L. Zweier, P. Kwiatkowski, and P. Kuppusamy
Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2129 - H2139.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. S. Lee and R. R. Makkar
Stem-Cell Transplantation in Myocardial Infarction: A Status Report
Ann Intern Med, May 4, 2004; 140(9): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-F. Xiao, J.-Y. Min, and J. P. Morgan
Immunosuppression and xenotransplantation of cells for cardiac repair
Ann. Thorac. Surg., February 1, 2004; 77(2): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Blatt, D. Robinson, G. Cotter, S. Efrati, Y. Simantov, I. Bar, E. Kaluski, R. Krakover, S. Sidenko, Z. Evron, et al.
Improved regional left ventricular function after successful satellite cell grafting in rabbits with myocardial infarction
Eur J Heart Fail, December 1, 2003; 5(6): 751 - 757.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Etzion, I. M. Barbash, M. S. Feinberg, P. Zarin, L. Miller, E. Guetta, R. Holbova, R. A. Kloner, L. H. Kedes, and J. Leor
Cellular Cardiomyoplasty of Cardiac Fibroblasts by Adenoviral Delivery of MyoD Ex Vivo: An Unlimited Source of Cells for Myocardial Repair
Circulation, September 24, 2002; 106(12_suppl_1): I-125 - I-130.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Yang, J.-Y. Min, J. S. Rana, Q. Ke, J. Cai, Y. Chen, J. P. Morgan, and Y.-F. Xiao
VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells
J Appl Physiol, September 1, 2002; 93(3): 1140 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-Y. Min, Y. Yang, K. L. Converso, L. Liu, Q. Huang, J. P. Morgan, and Y.-F. Xiao
Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats
J Appl Physiol, January 1, 2002; 92(1): 288 - 296.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Jain, H. DerSimonian, D. A. Brenner, S. Ngoy, P. Teller, A. S. B. Edge, A. Zawadzka, K. Wetzel, D. B. Sawyer, W. S. Colucci, et al.
Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction
Circulation, April 10, 2001; 103(14): 1920 - 1927.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R.-K. Li, R. D. Weisel, D. A. G. Mickle, Z.-Q. Jia, E.-J. Kim, T. Sakai, S. Tomita, L. Schwartz, M. Iwanochko, M. Husain, et al.
AUTOLOGOUS PORCINE HEART CELL TRANSPLANTATION IMPROVED HEART FUNCTION AFTER A MYOCARDIAL INFARCTION
J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 62 - 68.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens
Gene therapy in the cardiovascular system: an update
Cardiovasc Res, December 1, 1999; 44(3): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Allen
Myocardial protection: is there a role for gene therapy?
Ann. Thorac. Surg., November 1, 1999; 68(5): 1924 - 1928.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Sakai, R.-K. Li, R. D. Weisel, D. A.G. Mickle, Z.-Q. Jia, S. Tomita, E.-J. Kim, and T. M. Yau
FETAL CELL TRANSPLANTATION: A COMPARISON OF THREE CELL TYPES
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 715 - 725.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Rebolledo, P. Krogstad, F. Chen, K. M. Shannon, and T. S. Klitzner
Infection of Human Fetal Cardiac Myocytes by a Human Immunodeficiency Virus-1–Derived Vector
Circ. Res., October 5, 1998; 83(7): 738 - 742.
[Abstract] [Full Text] [PDF]